Trial Profile
A phase II study of GCS-100 in combination with chemo-immunotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2012
Price :
$35
*
At a glance
- Drugs GCS 100 (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 16 Nov 2008 New trial record.